US EditionContinuity Biosciences Appoints Josephine Torrente and Joseph DeSimone, PhD to Board of Directors
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
BRADENTON, Fla., August 6, 2025 /PRNewswire/ — Continuity Biosciences, pioneering a new generation of combination drug delivery technologies, today announced the appointment of two distinguished leaders to its Board of Directors: Josephine M. Torrente, Director at Hyman, Phelps & McNamara, P.C., and Dr. Joseph M. DeSimone, serial entrepreneur and Stanford University Professor. These appointments mark a significant step forward in Continuity's mi…
ADKhabar
ShareTrendingContinuity Biosciences Appoints Josephine Torrente and Joseph DeSimone, PhD to Board of Directors
BRADENTON, Fla., Aug. 6, 2025 /PRNewswire/ — Continuity Biosciences, a company pioneering next-generation combination product drug delivery, today announced the appointment of two highly distinguished leaders to its Board of Directors: Josephine M. Torrente, Director at Hyman, Phelps & McNamara, P.C., and Dr. Joseph M. DeSimone, serial entrepreneur and professor at Stanford University. These appointments […] The post Continuity Biosciences Appoi…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
